Covaxin for children over the age of two years will be available by September, according to Delhi AIIMS chief Randeep Guleria.

According to Delhi AIIMS chief Dr. Randeep Guleria, Covaxin, India’s first indigenous COVID-19 vaccine, will be accessible for children by September.

“Covaxin’s results for children following completion of the Phase 2/3 trials would be available by September, and the approval is expected the same month,” Guleria said in an interview with India Today TV.

Furthermore, he noted that if Pfizer-vaccine BioNTech’s is approved in India, it might be one of the options available to youngsters.

For June 7, the Delhi AIIMS began vaccination clinical trials on children aged 2 to 17.

Bharat Biotech was granted authorization by the Drugs Controller General of India (DCGI) in May to begin phase 2-3 trials of Covaxin on children as young as two years old.

Meanwhile, Guleria has warned that the third wave of COVID-19 might hit India in the next six to eight weeks if crowds are not controlled and laws are not followed.

“The third wave can occur in six to eight weeks if Covid-appropriate behavior is not followed. We must work quickly to prevent another large wave until vaccination becomes available “He revealed this to PTI.

The Subject Expert Committee (SEC) accepted and approved the phase 3 trial data of Covaxin, which showed 77.8 percent efficacy, on Tuesday (June 22), according to ANI. This information will now be forwarded to the DCGI for review.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker